Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 08
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,320,000
$132.85 P/Share
|
|
Apr 07
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Apr 07
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,179,000
$131.63 P/Share
|
|
Apr 07
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$655,000
$131.63 P/Share
|
|
Apr 07
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 06
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$858,000
$130.01 P/Share
|
|
Apr 06
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Apr 05
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-2.31%
|
$1,435,980
$130.03 P/Share
|
|
Apr 05
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-1.23%
|
$2,640,000
$132.63 P/Share
|
|
Apr 05
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.61%
|
$0
$0.99 P/Share
|
|
Apr 05
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$660,000
$132.63 P/Share
|
|
Apr 05
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 05
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-53.42%
|
$645,000
$129.33 P/Share
|
|
Apr 05
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 01
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$871,200
$132.51 P/Share
|
|
Apr 01
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Apr 01
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,320,000
$132.51 P/Share
|
|
Mar 31
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Mar 31
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,089,000
$121.1 P/Share
|
|
Mar 31
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$605,000
$121.1 P/Share
|
|
Mar 31
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Mar 31
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
4,888
-0.05%
|
$591,448
$121.07 P/Share
|
|
Mar 30
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$811,800
$123.3 P/Share
|
|
Mar 30
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Mar 30
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
2,112,795
-2.89%
|
$253,535,400
$120.82 P/Share
|
|
Mar 29
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
1,635,122
-1.34%
|
$206,025,372
$126.98 P/Share
|
|
Mar 29
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$650,000
$130.05 P/Share
|
|
Mar 29
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Mar 26
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.49%
|
$1,447,026
$131.85 P/Share
|
|
Mar 25
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$831,600
$126.88 P/Share
|
|
Mar 25
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Mar 25
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,260,000
$126.88 P/Share
|
|
Mar 24
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Mar 24
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,233,000
$137.07 P/Share
|
|
Mar 24
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$685,000
$137.07 P/Share
|
|
Mar 24
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Mar 24
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$685,000
$137.07 P/Share
|
|
Mar 24
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.31%
|
$50,000
$10.9 P/Share
|
|
Mar 23
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$957,000
$145.55 P/Share
|
|
Mar 23
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Mar 23
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.1%
|
$2,115,000
$141.21 P/Share
|
|
Mar 23
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+0.46%
|
$75,000
$5.95 P/Share
|
|
Mar 22
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$720,000
$144.19 P/Share
|
|
Mar 22
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Mar 22
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,199
-56.39%
|
$173,855
$145.26 P/Share
|
|
Mar 22
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,199
+50.0%
|
$23,980
$20.93 P/Share
|
|
Mar 19
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.87%
|
$1,568,532
$142.23 P/Share
|
|
Mar 18
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$950,400
$144.39 P/Share
|
|
Mar 18
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+24.75%
|
$151,800
$23.43 P/Share
|
|
Mar 18
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,440,000
$144.39 P/Share
|